Thijs van Iersel

807 total citations
17 papers, 626 citations indexed

About

Thijs van Iersel is a scholar working on Anesthesiology and Pain Medicine, Critical Care and Intensive Care Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Thijs van Iersel has authored 17 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Anesthesiology and Pain Medicine, 3 papers in Critical Care and Intensive Care Medicine and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Thijs van Iersel's work include Anesthesia and Sedative Agents (4 papers), Anesthesia and Neurotoxicity Research (3 papers) and Intensive Care Unit Cognitive Disorders (3 papers). Thijs van Iersel is often cited by papers focused on Anesthesia and Sedative Agents (4 papers), Anesthesia and Neurotoxicity Research (3 papers) and Intensive Care Unit Cognitive Disorders (3 papers). Thijs van Iersel collaborates with scholars based in Netherlands, United States and Germany. Thijs van Iersel's co-authors include Steven Ramael, Natalie Houwing, U. K. Nässander, Jean Smeets, Pierre Peeters, Alex Zwiers, Michiel W. van den Heuvel, Paul Passier, Wim H.A. Dokter and Michaëla Diamant and has published in prestigious journals such as Journal of the American College of Cardiology, Antimicrobial Agents and Chemotherapy and Anesthesiology.

In The Last Decade

Thijs van Iersel

16 papers receiving 594 citations

Peers

Thijs van Iersel
Yasuhisa Okuda Japan
Lila Papadimitriou Greece
G. C. Moudgil Canada
Takasuke Imai Japan
Sandrine Grosjean France
Vanessa Moll United States
J. Brennan McNeil United States
Sjoerd van Marle Netherlands
M Takaori Japan
Yasuhisa Okuda Japan
Thijs van Iersel
Citations per year, relative to Thijs van Iersel Thijs van Iersel (= 1×) peers Yasuhisa Okuda

Countries citing papers authored by Thijs van Iersel

Since Specialization
Citations

This map shows the geographic impact of Thijs van Iersel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thijs van Iersel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thijs van Iersel more than expected).

Fields of papers citing papers by Thijs van Iersel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thijs van Iersel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thijs van Iersel. The network helps show where Thijs van Iersel may publish in the future.

Co-authorship network of co-authors of Thijs van Iersel

This figure shows the co-authorship network connecting the top 25 collaborators of Thijs van Iersel. A scholar is included among the top collaborators of Thijs van Iersel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thijs van Iersel. Thijs van Iersel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Klein, Joshua P., Thijs van Iersel, Daniel H. de Vries, Yves Donazzolo, & Ingrid Klingmann. (2025). Healthy participant engagement in early clinical trials: results from the European EUFEMED survey. Frontiers in Pharmacology. 16. 1540948–1540948.
2.
Chamberlin, Paul, et al.. (2021). PHASE 1 SAFETY AND TOLERABILITY STUDY OF IMB-1018972, A NOVEL ORAL MODULATOR OF MYOCARDIAL SUBSTRATE UTILIZATION DESIGNED TO IMPROVE CARDIAC METABOLIC EFFICIENCY AND BIOENERGETICS. Journal of the American College of Cardiology. 77(18). 180–180. 4 indexed citations
3.
Iersel, Thijs van, et al.. (2021). The Patient Motivation Pyramid and Patient-Centricity in Early ClinicalDevelopment. PubMed. 17(1). 8–17. 4 indexed citations
4.
5.
6.
Kersemaekers, Wendy M., Thijs van Iersel, U. K. Nässander, et al.. (2014). Pharmacokinetics and Safety Study of Posaconazole Intravenous Solution Administered Peripherally to Healthy Subjects. Antimicrobial Agents and Chemotherapy. 59(2). 1246–1251. 56 indexed citations
7.
Akrawi, Sabah H., et al.. (2014). THU0150 Safety, Pharmacokinetics, Pharmacodynamics, and Food Effect of an Oral Bruton's Tyrosine Kinase Inhibitor HM71224 in Healthy Subjects. Annals of the Rheumatic Diseases. 73. 231–231. 3 indexed citations
8.
9.
Peeters, Pierre, Michiel W. van den Heuvel, Paul Passier, et al.. (2010). Safety, Tolerability and Pharmacokinetics of Sugammadex Using Single High Doses (Up to 96 mg/kg) in Healthy Adult Subjects. Clinical Drug Investigation. 30(12). 867–874. 53 indexed citations
10.
Raalte, Daniël H. van, Mathijs C. Bunck, Thijs van Iersel, et al.. (2010). Acute and 2-week exposure to prednisolone impair different aspects of β-cell function in healthy men. European Journal of Endocrinology. 162(4). 729–735. 132 indexed citations
11.
Iersel, Thijs van, et al.. (2010). Phase I study of Solulin, a novel recombinant soluble human thrombomodulin analogue. Thrombosis and Haemostasis. 105(2). 302–312. 23 indexed citations
12.
Schmidt, Monika, Peter de Boer, Erik Mannaert, Thijs van Iersel, & Luc Van Nueten. (2010). P.3.a.026 Safety, tolerability and D2 occupancy of the fast dissociating D2 antagonist JNJ-37822681 in healthy subjects. European Neuropsychopharmacology. 20. S444–S444. 2 indexed citations
13.
Peeters, Pierre, Michiel W. van den Heuvel, Paul Passier, et al.. (2010). Safety, Tolerability and Pharmacokinetics of Sugammadex Using Single High Doses (Up to 96 mg/kg) in Healthy Adult Subjects. Clinical Drug Investigation. 1–1. 50 indexed citations
14.
Schmidt, Mark E., et al.. (2009). P.1.e.024 D2 receptor occupancy with HC-raclopride PET following single and multiple dose: does steady state make a difference?. European Neuropsychopharmacology. 19. S314–S314. 1 indexed citations
15.
Peeters, P. A. M., Paul Passier, Jean Smeets, Thijs van Iersel, & Alex Zwiers. (2008). Single intravenous high-dose sugammadex (up to 96 mg/kg) is generally safe and well tolerated in healthy volunteers. European Journal of Anaesthesiology. 25(Sup 44). 132–132. 3 indexed citations
16.
Ramael, Steven, et al.. (2005). First Human Exposure of Org 25969, a Novel Agent to Reverse the Action of Rocuronium Bromide. Anesthesiology. 103(4). 695–703. 227 indexed citations
17.
Ramael, Steven, et al.. (2002). Preliminary Assessment of Org 25969 as a Reversal Agent for Rocuronium in Healthy Male Volunteers. Anesthesiology. 96(Sup 2). A1008–A1008. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasuhisa Okuda Breakdown of academic impact, for papers by Lila Papadimitriou Breakdown of academic impact, for papers by G. C. Moudgil Breakdown of academic impact, for papers by Takasuke Imai Breakdown of academic impact, for papers by Sandrine Grosjean Breakdown of academic impact, for papers by Vanessa Moll Breakdown of academic impact, for papers by J. Brennan McNeil Breakdown of academic impact, for papers by Sjoerd van Marle Breakdown of academic impact, for papers by M Takaori
Rankless by CCL
2026